These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 32678850)

  • 21. Correlates of Co-Occurring Diabetes and Obesity Among Community Mental Health Program Members With Serious Mental Illnesses.
    Cook JA; Razzano L; Jonikas JA; Swarbrick MA; Steigman PJ; Hamilton MM; Carter TM; Santos AB
    Psychiatr Serv; 2016 Nov; 67(11):1269-1271. PubMed ID: 27301761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
    Saloojee S; Burns JK; Motala AA
    PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey.
    Bahendeka S; Wesonga R; Mutungi G; Muwonge J; Neema S; Guwatudde D
    Trop Med Int Health; 2016 Mar; 21(3):405-16. PubMed ID: 26729021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Scope of Mental Illness and Status of Psychiatric Care in Uganda.
    Murray JS; Ainslie L; Alpough M; Schramm C; Showalter C
    Issues Ment Health Nurs; 2015; 36(11):877-83. PubMed ID: 26631859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based survey of overweight and obesity and the associated factors in peri-urban and rural Eastern Uganda.
    Kirunda BE; Fadnes LT; Wamani H; Van den Broeck J; Tylleskär T
    BMC Public Health; 2015 Nov; 15():1168. PubMed ID: 26602893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey.
    Guwatudde D; Mutungi G; Wesonga R; Kajjura R; Kasule H; Muwonge J; Ssenono V; Bahendeka SK
    PLoS One; 2015; 10(9):e0138991. PubMed ID: 26406462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.
    Asiki G; Murphy GA; Baisley K; Nsubuga RN; Karabarinde A; Newton R; Seeley J; Young EH; Kamali A; Sandhu MS
    PLoS One; 2015; 10(5):e0126166. PubMed ID: 25974077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence.
    Baller JB; McGinty EE; Azrin ST; Juliano-Bult D; Daumit GL
    BMC Psychiatry; 2015 Mar; 15():55. PubMed ID: 25885367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa.
    Saloojee S; Burns JK; Motala AA
    BMC Psychiatry; 2014 Aug; 14():228. PubMed ID: 25113131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
    James PA; Oparil S; Carter BL; Cushman WC; Dennison-Himmelfarb C; Handler J; Lackland DT; LeFevre ML; MacKenzie TD; Ogedegbe O; Smith SC; Svetkey LP; Taler SJ; Townsend RR; Wright JT; Narva AS; Ortiz E
    JAMA; 2014 Feb; 311(5):507-20. PubMed ID: 24352797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
    Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
    Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.
    Mitchell AJ; Vancampfort D; Sweers K; van Winkel R; Yu W; De Hert M
    Schizophr Bull; 2013 Mar; 39(2):306-18. PubMed ID: 22207632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does colocated care improve access to cardiometabolic screening for patients with serious mental illness?
    Kilbourne AM; Lai Z; Bowersox N; Pirraglia P; Bauer MS
    Gen Hosp Psychiatry; 2011; 33(6):634-6. PubMed ID: 21872334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
    Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.
    Mitchell AJ; Delaffon V; Vancampfort D; Correll CU; De Hert M
    Psychol Med; 2012 Jan; 42(1):125-47. PubMed ID: 21846426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients.
    Correll CU; Druss BG; Lombardo I; O'Gorman C; Harnett JP; Sanders KN; Alvir JM; Cuffel BJ
    Psychiatr Serv; 2010 Sep; 61(9):892-8. PubMed ID: 20810587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and classification of diabetes mellitus.
    American Diabetes Association
    Diabetes Care; 2010 Jan; 33 Suppl 1(Suppl 1):S62-9. PubMed ID: 20042775
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).
    De Hert M; Dekker JM; Wood D; Kahl KG; Holt RI; Möller HJ
    Eur Psychiatry; 2009 Sep; 24(6):412-24. PubMed ID: 19682863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality and medical comorbidity among patients with serious mental illness.
    Miller BJ; Paschall CB; Svendsen DP
    Psychiatr Serv; 2006 Oct; 57(10):1482-7. PubMed ID: 17035569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.